BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28866900)

  • 1. Patient preference for stereotactic radiosurgery plus or minus whole brain radiotherapy for the treatment of brain metastases.
    Zeng KL; Raman S; Sahgal A; Soliman H; Tsao M; Wendzicki C; Chow E; Lo SS
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S155-S160. PubMed ID: 28866900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
    Brown PD; Jaeckle K; Ballman KV; Farace E; Cerhan JH; Anderson SK; Carrero XW; Barker FG; Deming R; Burri SH; Ménard C; Chung C; Stieber VW; Pollock BE; Galanis E; Buckner JC; Asher AL
    JAMA; 2016 Jul; 316(4):401-409. PubMed ID: 27458945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases.
    Lester-Coll NH; Dosoretz AP; Yu JB
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):563-8. PubMed ID: 24751412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous.
    Nieder C; Guckenberger M; Gaspar LE; Rusthoven CG; De Ruysscher D; Sahgal A; Nguyen T; Grosu AL; Mehta MP
    Radiat Oncol; 2019 Feb; 14(1):33. PubMed ID: 30770745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-institutional study of factors influencing the use of stereotactic radiosurgery for brain metastases.
    Hodgson DC; Charpentier AM; Cigsar C; Atenafu EG; Ng A; Bahl G; Zadeh G; San Miguel J; Menard C
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):335-40. PubMed ID: 22704984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
    J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole Brain Radiotherapy Combined with Stereotactic Radiosurgery versus Stereotactic Radiosurgery Alone for Brain Metastases.
    Adas YG; Yazici O; Kekilli E; Akkas EA; Karakaya E; Ucer AR; Ertas G; Calikoglu T; Elgin Y; Inan GA; Kocer AM; Guney Y
    Asian Pac J Cancer Prev; 2015; 16(17):7595-7. PubMed ID: 26625767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
    Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
    Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer.
    Monaco EA; Faraji AH; Berkowitz O; Parry PV; Hadelsberg U; Kano H; Niranjan A; Kondziolka D; Lunsford LD
    Cancer; 2013 Jan; 119(1):226-32. PubMed ID: 22707281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery (SRS) alone versus whole brain radiotherapy plus SRS in patients with 1 to 4 brain metastases from non-small cell lung cancer stratified by the graded prognostic assessment: A meta-analysis (PRISMA) of randomized control trials.
    Qie S; Li Y; Shi HY; Yuan L; Su L; Zhang X
    Medicine (Baltimore); 2018 Aug; 97(33):e11777. PubMed ID: 30113464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring.
    Shen CJ; Rigamonti D; Redmond KJ; Kummerlowe MN; Lim M; Kleinberg LR
    Pract Radiat Oncol; 2016; 6(6):409-416. PubMed ID: 27687187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.
    Halasz LM; Uno H; Hughes M; D'Amico T; Dexter EU; Edge SB; Hayman JA; Niland JC; Otterson GA; Pisters KM; Theriault R; Weeks JC; Punglia RS
    Cancer; 2016 Jul; 122(13):2091-100. PubMed ID: 27088755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Stereotactic Radiosurgery in Elderly and Very Elderly Patients With Brain Metastases to Limit Toxicity Associated With Whole Brain Radiation Therapy.
    Chen L; Shen C; Redmond KJ; Page BR; Kummerlowe M; Mcnutt T; Bettegowda C; Rigamonti D; Lim M; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):939-947. PubMed ID: 28602418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.